These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4153166)

  • 1. 2-(2,4-dichlorophenoxy) phenylacetic acid (fenclofenac): one of a novel series of anti-inflammatory compounds with low ulcerogenic potential.
    Atkinson DC; Godfrey KE; Jordan BJ; Leach EC; Meek B; Nichols JD; Saville JF
    J Pharm Pharmacol; 1974 May; 26(5):357-8. PubMed ID: 4153166
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-inflammatory and related properties of 2-(2,4-dichlorophenoxy)phenylacetic acid (fenclofenac).
    Atkinson DC; Leach EC
    Agents Actions; 1976 Sep; 6(5):657-66. PubMed ID: 970297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terpene compounds as drugs. X. 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370): a new anti-inflammatory drug, with low ulcerogenic effects, derived from a series of terpenyl pyrazolidinediones.
    Casadio S; Pala G; Marazzi-Uberti E; Lumachi B; Crescenzi E; Donetti A; Mantegani A; Bianchi C
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:171-4. PubMed ID: 5067187
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-inflammatory properties of 4,5-diphenyl-2-oxazolepropionic acid (oxaprozin).
    Rosenthale ME; Begany AJ; Dervinis A; Malis JL; Shriver DA; Datko SL; Gluckman MI
    Agents Actions; 1974 Aug; 4(3):151-9. PubMed ID: 4412045
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of direct tissue contact in the production of gastrointestinal ulcers by anti-inflammatory drugs in rats.
    Cioli V; Putzolu S; Rossi V; Scorza Barcellona P; Corradino C
    Toxicol Appl Pharmacol; 1979 Sep; 50(2):283-9. PubMed ID: 505458
    [No Abstract]   [Full Text] [Related]  

  • 6. Sodium (o-((2,6-dichlorophenyl)-amino)-phenyl)-acetate (GP 45 840), a new non-steroidal anti-inflammatory agent.
    Krupp PJ; Menassé-Gdynia R; Sallmann A; Wilhelmi G; Ziel R; Jaques R
    Experientia; 1973 Apr; 29(4):450-2. PubMed ID: 4708344
    [No Abstract]   [Full Text] [Related]  

  • 7. Species differences in susceptibility to the gastro-ulcerogenic action of anti-inflammatory agents.
    Wilhelmi G
    Pharmacology; 1974; 11(4):220-30. PubMed ID: 4460013
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacologic evaluation of tolectin (tolmetin, mcn-2559) and mcn-2891, two anti-inflammatory agents.
    Wong S; Gardocki JF; Pruss TP
    J Pharmacol Exp Ther; 1973 Apr; 185(1):127-38. PubMed ID: 4571334
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 7. Pharmacological comparison with standard anti-inflammatory drugs.
    Marazzi-Uberti E; Lumachi B; Gaetani M; Coppi G; Bianchi C
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:213-6. PubMed ID: 5067195
    [No Abstract]   [Full Text] [Related]  

  • 10. Nonsteroidal antiinflammatory agents. 1.2,4-Diphenylthiazole-5-acetic acid and related compounds.
    Brown K; Cater DP; Cavalla JF; Green D; Newberry RA; Wilson AB
    J Med Chem; 1974 Nov; 17(11):1177-81. PubMed ID: 4414839
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiinflammatory activity of the new mould metabolite 11-desacetoxy-wortmannin and of some of its derivatives.
    Wiesinger D; Gubler HU; Haefliger W; Hauser D
    Experientia; 1974 Feb; 30(2):135-6. PubMed ID: 4814585
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 2. Ulcerogenic effects in rats and dogs.
    Marazzi-Uberti E; Bianchi C; Gaetani M; Pozzi L
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:191-6. PubMed ID: 5067472
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and pharmacology of a novel anti-inflammatory agent, ID-1619.
    Komatsu T; Awata H; Sakai Y; Inukai T; Kimura M; Inaba S; Yamamoto H
    Arzneimittelforschung; 1972 Dec; 22(12):2099-104. PubMed ID: 4541096
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative study of the ulcerogenic action of various oral non-steroid anti-inflammatory drugs in the rat].
    Sardal J; Baillet J; Ferrero E; Guzzon V
    Therapie; 1972; 27(3):483-9. PubMed ID: 4655213
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative gastric ulcerogenic effects of meseclazone, 5-chlorosalicylic acid and other nonsteroidal anti-inflammatory drugs following acute and repeated oral administration to rats.
    Diamantis W; Melton J; Sofia RD; Ciofalo VB
    Toxicol Appl Pharmacol; 1980 Mar; 52(3):454-61. PubMed ID: 6768168
    [No Abstract]   [Full Text] [Related]  

  • 16. Ulcerogenic properties of anti-inflammatory drugs.
    O'Brien WM
    Pharmacology; 1982; 25 Suppl 1():9-11. PubMed ID: 7111388
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological activity and toxicity of apyramide: comparison with non-steroidal anti-inflammatory agents.
    Sauvaire D; Michel A; Serrano JJ; Richard M
    Drugs Exp Clin Res; 1987; 13(5):247-52. PubMed ID: 3500027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alclofenac in rheumatoid arthritis: an evaluation of its anti-inflammatory and analgesic effects.
    Aylward M
    Br J Clin Pract; 1973 Jul; 27(7):255-60. PubMed ID: 4580332
    [No Abstract]   [Full Text] [Related]  

  • 19. [Preliminary pharmacologic trials of new phenylbutazone esters].
    Sugawara SH; Oga S; Yasaka WJ; Santoro MI
    Boll Chim Farm; 1978 Feb; 117(2):90-101. PubMed ID: 743362
    [No Abstract]   [Full Text] [Related]  

  • 20. A sensitive method for the comparative bioassay of nonsteroidal anti-inflammatory compounds in adjuvant-induced primary inflammation in the rat.
    Wax J; Tessman DK; Winder CV; Stephens MD
    J Pharmacol Exp Ther; 1975 Jan; 192(1):166-71. PubMed ID: 1123721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.